regulatory

Big Pharma Needs A Better Business Model, Not More Legislation
Big Pharma Needs A Better Business Model, Not More Legislation
Forbes
regulatory
legislation
PBMs
Flag link:
State laws trying to force drug price transparency come up short, study says
State laws trying to force drug price transparency come up short, study says
Fierce Pharma
states
regulatory
drug pricing
transparency
Flag link:
The top drugs facing cuts under Pelosi's pricing plan
The top drugs facing cuts under Pelosi's pricing plan
Biopharma Dive
drug pricing
Nancy Pelosi
regulatory
Revlimid
Keytruda
Opdivo
Januvia
insulin
Medicare
Flag link:
Price rollbacks, Medicare negotiations, fines and more: Pharma's likely to hate House pricing plan
Price rollbacks, Medicare negotiations, fines and more: Pharma's likely to hate House pricing plan
Fierce Pharma
drug pricing
regulatory
Nancy Pelosi
Flag link:
States passing record number of laws to control drug pricing
States passing record number of laws to control drug pricing
Beckers Hospital Review
drug pricing
regulatory
Flag link:
The FDA and Sarepta: a window into the real world of drug regulation
The FDA and Sarepta: a window into the real world of drug regulation
Stat
FDA
regulatory
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Exondys 51
Vyondys 53
Flag link:
Senate's Prescription Drug Pricing Bill's Limited Impact On Drug Prices
Senate's Prescription Drug Pricing Bill's Limited Impact On Drug Prices
Forbes
Sentate
regulatory
drug pricing
Flag link:
FDA rebuffs allegations that it has deprioritized enforcement
FDA rebuffs allegations that it has deprioritized enforcement
BioCentury
FDA
regulatory
Flag link:
It’s a big week for debates about drug prices, whether pharma likes it or not
It’s a big week for debates about drug prices, whether pharma likes it or not
Stat
drug pricing
regulatory
US Congress
patents
Flag link:
5 Things You'll Want to Watch With GW Pharmaceuticals
5 Things You'll Want to Watch With GW Pharmaceuticals
Motley Fool
GW Pharma
Epidiolex
Europe
Sativex
regulatory
Flag link:
The gene therapy era has arrived. So have the challenges.
The gene therapy era has arrived. So have the challenges.
Biopharma Dive
cell therapy
gene therapy
FDA
regulatory
Novartis
Zolgensma
Flag link:
FDA to Explore Randomized Trials Using RWE for Regulatory Purposes
FDA to Explore Randomized Trials Using RWE for Regulatory Purposes
RAPS.org
FDA
RWE
regulatory
Flag link:
White House, Congress considering killing Part D rebate rule, creating spending cap
White House, Congress considering killing Part D rebate rule, creating spending cap
BioCentury
regulatory
drug pricing
Medicare
Medicare Part D
Flag link:
Drug Industry Patents Go Under Senate Judiciary Committee’s Microscope
Drug Industry Patents Go Under Senate Judiciary Committee’s Microscope
KHN
patents
drug pricing
innovation
regulatory
Flag link:
Should Patients Have a Say in Medical Device Regulatory Matters?
Should Patients Have a Say in Medical Device Regulatory Matters?
Medical Devices and Diagnostics Industry
FDA
devices
regulatory
patients
Flag link:
What Are Biopharma Leaders Focused on?
What Are Biopharma Leaders Focused on?
BioSpace
drug pricing
regulatory
innovation
value-based drug pricing
government
Alzheimer's disease
drug manufacturing
Flag link:
Balancing Benefit and Risk in Medical Device Regulation
Balancing Benefit and Risk in Medical Device Regulation
FDA Law Blog
devices
risk
regulatory
FDA
Flag link:
What Will Keep Medtech up at Night in 2019?
What Will Keep Medtech up at Night in 2019?
Medical Devices and Diagnostics Industry
devices
taxes
cybersecurity
reimbursement
trade
technology
regulatory
patients
physicians
Flag link:
Here are 5 medtech industry trends you need to know
Here are 5 medtech industry trends you need to know
Mass Device
devices
M&A
grants
academia
regulatory
intellectual property
Flag link:
What is the future of medtech in 2019?
What is the future of medtech in 2019?
Medical Design and Outsourcing
devices
regulatory
technology
telehealth
Flag link:

Pages